Special Report
The Big 280E Gamble
How Florida's licensed medical marijuana operators are betting on federal 280E tax reform — and what's at stake if it doesn't come.
Section 280E of the federal tax code bars businesses that traffic in Schedule I or II controlled substances from deducting ordinary operating expenses. For Florida's vertically integrated cannabis operators (MMTCs), that means effective tax rates far above those of a normal retail or agriculture business — a structural drag on every dollar of revenue.
This report examines how Florida operators are positioning themselves around the possibility of rescheduling and 280E relief: who is taking aggressive tax positions, who is reserving for back taxes, and how the outcome could reshape margins, expansion plans, and the competitive map across the state.
We walk through the numbers behind the gamble — the cash-flow impact at current rates, the upside if 280E no longer applies, and the downside risk for companies that have already booked the benefit before the rules actually change.
What's inside the full report
- How 280E works and why it hits cannabis uniquely hard
- The rescheduling timeline and what would trigger relief
- Operator-by-operator exposure across Florida MMTCs
- Margin and cash-flow scenarios under each outcome
- What the gamble means for patients and prices
The complete analysis is free for members. Sign in or create a free account to read it.